Kalshi Traders Eye IonQ Micron Anduril as Potential US Government Stake Targets After Quantum Investments Robinhood Unveils AI Agents for Automated Trading and Spending Jim Cramer Advises Investors to Focus on AI Stocks Upside Potential Not Past Performance Fox Corporation Shares Dip in Q1 After Strong Prior Run Palantir Accuses London Mayor Sadiq Khan of Politicizing Procurement After 50m Met Police Contract Blocked Anand Rathi Analyst Highlights Three Banking Stocks Under 200 for ShortTerm Consideration NetSTREIT Corp NTST Q1 2026 Earnings EPS Misses Street View Shares Dip on Weaker Profitability Vista Energy Q1 2026 Earnings Strong EPS Performance Amid Market Adjustment Purple Biotech Ltd PPBT Q1 2025 Earnings ClinicalStage Biotech Reports Net Loss as Pipeline Advances LFUS Q1 2026 Earnings Strong EPS Beat Exceeds Analyst Expectations IPHA Q1 2026 Earnings WiderthanExpected Loss Amid Pipeline Progress CCNE Q1 2026 Earnings EPS Beats Estimates Amidst Mixed Market Reaction ZKH Group Limited ZKH Gains 179 as Stock Approaches Key Resistance Level The Marygold Companies Inc MGLD Gains 446 as Shares Test Key Resistance at 123 BrightSpire Capital BRSP Holds Steady at 568 as Trading Range Tightens Asbury Automotive Group ABG Edges Higher as Buyers Test Resistance Near 197 SKK Holdings Limited Slips Nearly 3 as Support Levels Come into Focus Rapid7 RPD Q1 2026 Earnings EPS Surges Past Estimates as Cybersecurity Demand Remains Strong AMSC Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism EWBC Q1 2026 Earnings EPS Beats Estimates Shares Tick Higher Catheter Precision Inc Q1 2025 Earnings EPS Misses Estimates by Wide Margin Stock Rises Despite Deep Loss Wellgistics Health Inc WGRX Q1 2026 Earnings Narrowed Loss Fails to Lift Market Sentiment Heritage Global Inc HGBL Q1 2026 Earnings EPS Misses Estimates as Company Reports Modest Profits SEBI Chief Tuhin Kanta Pandey Indias Market Diversification Remains Key Advantage Over Taiwans Concentrated Growth ABCL Q1 2026 Earnings EPS Surprises to the Upside as Biotech Continues Development Ultragenyx RARE Inches Higher Amid Biotech Sector Volatility